Harvest Fund Management Co., Ltd

Position in EXEL — Exelixis, Inc.

CIK 1694126 BEIJING, F4

Position in EXEL

as of Jun 30, 2026 · filed Aug 20, 2026 Compact

Position Value

$418,902

+$83,932 QoQ

Shares Held

7,699

-1.4% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#462

of 751 holders

Holding Since

Sep 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Harvest Fund Management Co., Ltd holds $18,814,641 across 10 Biotechnology names. EXEL ranks #5 (2.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	19,560	$9,716,038
2	REGN	Regeneron Pharmaceuticals, Inc.	7,900	$4,925,966
3	ALNY	Alnylam Pharmaceuticals, Inc.	9,981	$3,004,580
4	HALO	Halozyme Therapeutics, Inc.	7,432	$581,702
5	EXEL	Exelixis, Inc. This page	7,699	$418,902
6	BBIO	BridgeBio Pharma, Inc.	892	$66,436
7	BNTX	BioNTech SE	600	$55,830
8	INCY	Incyte Corp	184	$20,858

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$418,902	7,699	-1.4%	Shares	Sole	2026-08-20
2026-03-31	$334,970	7,810	-1.5%	Shares	Sole	2026-05-14
2025-12-31	$347,440	7,927	+190.6%	Shares	Sole	2026-02-11
2025-09-30	$112,666	2,728	-87.3%	Shares	Sole	2025-11-14
2025-06-30	$947,323	21,491	-0.8%	Shares	Sole	2025-08-15
2025-03-31	$800,204	21,674	+64.2%	Shares	Sole	2025-05-08
2024-12-31	$439,626	13,202	+6567.7%	Shares	Sole	2025-02-11
2023-12-31	$4,750	198	-74.1%	Shares	Sole	2024-02-02
2023-09-30	$16,693	764	+506.3%	Shares	Sole	2023-11-07
2023-06-30	$2	126	-96.2%	Shares	Sole	2023-07-07
2023-03-31	$64,693	3,333	+107.1%	Shares	Sole	2023-05-11
2020-09-30	$39,340	1,609	—	Shares	Sole	2020-11-04
No filing history on record for this holder in this stock.